Undergoing IVF with preimplantation genetic testing (PGT) is a multi-phase journey that requires careful planning and realistic expectations about timing.
Unlike a standard IVF cycle – which can conclude with a fresh embryo transfer in as little as four to six weeks – a PGT cycle requires freezing your embryos while cellular samples are analyzed at a genetics laboratory.
This makes a fresh transfer impossible and extends the overall process considerably.
However, the payoff is significant: selecting a genetically normal (euploid) embryo dramatically reduces miscarriage risk, improves implantation success rates, and, for many patients, shortens the overall time to a healthy pregnancy by reducing failed transfer attempts.
This guide walks you through every phase of the IVF timeline with PGT, including exact wait times, what happens during the genetic testing period, how the frozen embryo transfer cycle works, and what to expect if results are unexpected.
Key Takeaways
Standard IVF vs. IVF with PGT: Where the Timelines Diverge

The easiest way to understand why PGT adds time is to see where the two pathways split:
In a PGT cycle, the retrieval and transfer happen in completely separate menstrual cycles. The first cycle focuses on creating and testing embryos. The second cycle focuses on preparing the uterus to receive a genetically vetted embryo.
This structural split is the primary source of the extended timeline, not the testing itself.
The IVF Timeline with PGT: Phase by Phase
Phase 1: Pre-Cycle Preparation and Diagnostic Testing (Weeks 1–4)
Before any stimulation medications begin, your fertility specialist builds a complete picture of your reproductive profile and, if applicable, prepares the genetics laboratory for your specific test type.
Diagnostic workup includes:
- Antral follicle count (AFC) via transvaginal ultrasound, which guides stimulation dosing
- Blood panels: AMH (ovarian reserve), FSH, LH, estradiol, prolactin
- Infectious disease screening
- Semen analysis, which determines whether ICSI will be used for fertilization
- Uterine evaluation (baseline sonohysterogram or hysteroscopy if indicated)
- Genetic carrier screening (if family history suggests PGT-M may be needed)
Each medication serves a specific purpose at a specific phase: birth control pills for cycle synchronization before stimulation begins, gonadotropins for follicle growth during stimulation, and progesterone and estrogen support the uterine lining through transfer and early pregnancy.
Duration: 2–4 weeks for PGT-A; 4–8 weeks if PGT-M probe preparation is required.
Phase 2: Ovarian Stimulation (Days 1–14 of Active Cycle)
Ovarian stimulation is the same whether or not PGT is included. The goal is to coax the ovaries into maturing multiple follicles simultaneously, giving you the best chance of producing several embryos for testing.
What happens:
- Hormone injections (gonadotropins containing FSH, with or without LH) begin on Day 2 or 3 of your menstrual cycle.
- You will visit the clinic every 2–3 days for blood tests and ultrasounds to monitor follicle growth and adjust your dosing.
- When lead follicles reach 18–22mm, a trigger shot initiates the final 36-hour maturation window before egg retrieval.
- Your team monitors throughout for signs of ovarian hyperstimulation syndrome (OHSS), a condition where the ovaries over-respond to stimulation medication, which can require modifying or postponing retrieval.
- Egg retrieval is scheduled exactly 36 hours after the trigger shot.
The trigger shot is one of the most time-sensitive injections in the entire IVF protocol; administering it even a few hours late can affect egg maturity at retrieval, so your clinic will give very precise timing instructions.
Duration: 10–14 days of injections.
Phase 3: Egg Retrieval and Embryo Culture (Days 0–6 Post-Retrieval)
Egg retrieval is a brief, outpatient procedure performed under light IV sedation. It takes 20–30 minutes, and most patients go home the same day with minimal recovery time.
The IVF Funnel: Realities of Embryo Attrition
One of the most important things PGT patients should understand is that not every retrieved egg becomes a transferable embryo. Attrition at each stage is expected:
| Stage | Typical Rate |
|---|---|
| Eggs retrieved | 100% |
| Mature eggs (MII) | ~70–80% |
| Successfully fertilized | ~60–70% of mature eggs |
| Reach blastocyst (Day 5/6) | ~40–60% of fertilized eggs |
| Euploid (pass PGT) | Highly dependent on maternal age; see below |
Expected euploid rate by maternal age (based on published blastocyst biopsy outcomes data from SART and peer-reviewed embryology literature):
This is why your reproductive endocrinologist may recommend banking embryos across multiple retrieval cycles before scheduling a transfer, particularly for patients over 38 or those with diminished ovarian reserve.
The goal is to accumulate enough euploid embryos to give you meaningful transfer attempts.
The Blastocyst Biopsy
On Day 5, 6, or occasionally Day 7, embryos that have reached the blastocyst stage (approximately 100–200 cells) undergo biopsy. An embryologist uses a precision laser to remove 3–8 cells from the trophectoderm, the outer cell layer destined to become the placenta. The inner cell mass (which becomes the baby) is never touched.
Immediately after biopsy, each embryo is vitrified (flash-frozen) and stored at Coastal Fertility. The biopsied cell samples are shipped overnight to the genetics reference lab.
Duration: 5–7 days from retrieval to biopsy and freeze.
Phase 4: Genetic Laboratory Analysis – The Waiting Period (7 to 21 Days)
This is the phase that most patients find emotionally difficult. Your embryos are safely frozen while you wait for results you cannot control.
Understanding exactly what is happening at the lab, and how long each test type takes, can help manage the uncertainty:
| Test Type | Full Name | What It Screens For | Avg. Turnaround | Pre-Cycle Prep? |
|---|---|---|---|---|
| PGT-A | Preimplantation Genetic Testing for Aneuploidy | Missing or extra chromosomes (e.g., Down syndrome / Trisomy 21). Most common cause of IVF failure and miscarriage. | 7–10 business days | No |
| PGT-M | Preimplantation Genetic Testing for Monogenic/Single-Gene Defects | Inherited conditions (cystic fibrosis, Huntington’s, BRCA mutations, sickle cell disease, Tay-Sachs) | 10–14 business days | Yes — 4–6 weeks |
| PGT-SR | Preimplantation Genetic Testing for Structural Rearrangements | Chromosomal translocations, inversions, deletions linked to recurrent pregnancy loss | 10–14 business days | Sometimes |
How to read your results:
Duration: 7–21 days, depending on test type.
Phase 5: Frozen Embryo Transfer (FET) Preparation and Transfer (3–6 Weeks)
Once results arrive and a euploid embryo is identified, your care team coordinates the FET cycle, which begins in your next menstrual cycle.
Two FET protocol options:
- Estrogen (patches, pills, or injections) for approximately 10–14 days to build the uterine lining
- Monitoring ultrasound to confirm lining thickness (target: ≥7mm with a triple-layer pattern)
- Progesterone added 5–6 days before the scheduled transfer
- Transfer takes 15–20 minutes; a thin catheter guided by ultrasound places the thawed embryo at the optimal uterine position
- No sedation required; most patients return to normal activities the same day
- Monitoring tracks the body’s natural LH surge to time progesterone start
- Slightly shorter overall but requires more intensive monitoring
- Less predictable scheduling than medicated protocol
How many days from egg retrieval to embryo transfer with PGT? Most patients transfer approximately 6 to 10 weeks after their egg retrieval, accounting for 1-2 weeks of genetic testing plus 4–6 weeks of FET preparation.
Duration: 4–6 weeks from the start of FET medication to transfer day.
Phase 6: The Two-Week Wait and Pregnancy Confirmation (14 Days)
After your embryo transfer is complete, the focus shifts entirely to cellular implantation. For many patients, this is the most emotionally intense period of the entire IVF journey. If you are wondering how soon after frozen embryo transfer you can test, it helps to understand how the hormonal timeline actually works.
The implantation window: A Day 5 frozen blastocyst typically implants within 1 to 3 days following your transfer procedure. During this window, the embryo sheds its protective shell (zona pellucida) and attaches to the uterine lining, a process that cannot be felt and cannot be influenced once transfer has occurred.
hCG production: Once implantation is successful, the developing trophoblast cells begin producing human chorionic gonadotropin (hCG). This hormone doubles in concentration approximately every 48 hours in a healthy early pregnancy and is what both blood tests and home pregnancy tests detect.
When to test after frozen embryo transfer:
Ongoing medication: Continue all progesterone support (and estrogen, if on a medicated protocol) throughout the two-week wait and beyond until your clinic advises otherwise; stopping early can compromise the uterine environment for an embryo that has successfully implanted.
If the beta is negative: Most patients with remaining frozen euploid embryos can proceed to a second FET without repeating the full retrieval and stimulation cycle. Your specialist will review the protocol and, if multiple FETs have not resulted in pregnancy, may recommend an ERA (endometrial receptivity assay) to optimize timing for the next transfer.
IVF with PGT Timeline (Summary Table)
| Phase | Duration | Cumulative Total |
|---|---|---|
| Pre-cycle testing and prep | 2–4 weeks (PGT-A) or 4–8 weeks (PGT-M) | Weeks 1–4 |
| Ovarian stimulation | 10–14 days | Weeks 3–6 |
| Egg retrieval + embryo culture | 5–7 days | Weeks 5–7 |
| Embryo biopsy + genetic testing | 7–21 days | Weeks 6–10 |
| FET preparation (medicated protocol) | 4–6 weeks | Weeks 8–14 |
| Two-week wait | 14 days | Weeks 10–16 |
| First consultation to pregnancy test | 10–16 weeks total | ~3–4 months |
The “8–12 week” figure quoted by some clinics refers only to the window from stimulation start to transfer; it excludes pre-cycle prep. Planning for 3–4 months from your first appointment gives you a realistic and practical expectation.
What Can Delay the IVF with PGT Timeline?
The phases above represent a smooth, uninterrupted cycle. In practice, several factors commonly cause delays.
Is IVF with PGT Worth the Extra Time?
For many patients, yes; and the data support this. Compared to untested embryo transfers:
The caveat: PGT is not universally right for every patient. Those with very limited ovarian reserve may not have enough blastocysts for testing. Younger patients with high-quality embryos and no genetic risk factors may reasonably choose to skip it.
Cost is also a real consideration; PGT typically adds $3,000–$6,000 or more on top of the base IVF cycle cost, covering the biopsy procedure, genetic lab fees, and embryo freezing.
This decision should always be made with your reproductive endocrinologist based on your age, diagnosis, embryo history, and goals.
Coastal Fertility’s preimplantation genetic testing program includes both PGT-A and PGT-M. Throughout the process, your assigned fertility doctor and clinical team will personally guide you, explain your treatment options, and help you create a customized plan tailored to your unique situation
Final Thoughts
The IVF timeline with PGT requires patience, but every additional week is purposeful. By separating the embryo creation phase from the transfer phase, PGT gives your medical team the genetic clarity needed to select the embryo most likely to become a healthy baby.
At Coastal Fertility Medical Center, every patient receives a personalized timeline before treatment begins, so you know exactly what to expect and when.
Frequently Asked Questions
Why can’t you do a fresh transfer with PGT? +
How long do PGT results take to come back from the lab? +
How long after PGT testing is the transfer? +
How many days after egg retrieval is the embryo transfer with PGT? +
Does PGT testing damage the embryo? +
How many embryos typically pass PGT? +
What happens if no embryos pass PGT? +
Julianna Nikolic
Chief Strategy Officer Julianna Nikolic leads strategic initiatives, focusing on growth, innovation, and patient-centered solutions in the reproductive sciences sector. With 26+ years of management experience and a strong entrepreneurial background, she brings deep expertise to advancing reproductive healthcare.








